Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Developmental |
| Species: | Human |
| Stage: | Concluded, no further activity expected |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
An open-label, passive antibody trial to assess efficacy in the pathogenic SHIV-89.6P macaque model of human antibodies generated by a candidate HIV-1 vaccine in a Phase I clinical trial
Description
HVTN 803 is a combination open-label clinical trial and non-human primate challenge study where macaques are infused with antibodies from participants who received ALVAC-HIV (vCP205 or vCP300) and SF-2 rgp120, and boosted with gp160MN/LAI-2.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.